Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes

Blood

Volumn 86, Issue 1, 1995, Pages 268-276

  Raza, Azra ^a,b   Gezer, Sefer ^a   Mundle, Suneel ^a   Gao, Xue Zhi ^a   Alvi, Sairah ^a   Borok, Raphael ^a   Rifkin, Shelby ^a   Iftikhar, Amna ^a   Shetty, Vilasini ^a   Parcharidou, Agapi ^a   Loew, Jerome ^a   Marcus, Bridget ^a   Khan, Zaineb ^a   Chaney, Colette ^a   Showel, John ^a   Gregory, Stephanie ^a   Preisler, Harvey ^a  

^a Department of Medicine ^*

^b RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; IDOXURIDINE;

APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL;

EID: 0029020851     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.1.268.bloodjournal861268     Document Type: Article

References (35)

1. Willemze R, Fibbe WE, Falkenburg JHF, Kluin-Nelemans JC, Kluin PM, Landegent JE: Biology and treatment of myelodysplastic syndromes-developments in the past decade. Ann Hematol 66:107, 1993
2. Ganser A, Hoelzer D: Treatment of myelodysplastic syndromes with hematopoietic growth factors. Hematol-Oncol Clin N Am 6:633, 1992
3. Loffler H, Schmitz N, Gassmann W: Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Hematol-Oncol Clin N Am 6:619, 1992
4. Abrahamson G, Boultwood J, Madden J, Kelly S, Oscier DG, Rack K, Buckle VJ, Wainscoat JS: Clonality of cell populations in refractory anemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analysis. Br J Haematol 79:550, 1991
5. Jowitt SN, Yin JAL, Saunders MJ: Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia. Blood 82:613, 1993
6. Anastasi J, Feng J, LeBeau MM, Larson RA, Rowley JD, Vardiman JW: Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: Lineage, response to growth factor therapy and clonal expansion. Blood 81:1580, 1993
7. Tricot G, Boogaerts MA, Wolf-Peeters CD: The myelodysplastic syndromes: Different evolution pattern based on sequential morphological and cytogenetic investigations. Br J Haematol 59:659. 1985
8. Nöel P, Tefferi A, Pierre RV, Jenkins RB, Dewald GW: Karyo-typic analysis in primary myelodysplastic syndromes. Blood Reviews 7:10, 1993
9. Paquette RL, Landaw EM, Pierre RV, Kahan J, Lubbert M, Lazanco O. Isaac G, McCormick F, Koeffler HP: N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood 82:590, 1993
10. Anderson JE, Appelbaum FR, Fisher LD, Stoch G, Shulman H, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Doney K, Martin PJ, Sanders JE, Sullivan KM, Thomas ED, Witherspoon RP, Hansen JA, Storb R: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 82:677, 1993
11. Wyllie AH: Apoptosis. Br J Cancer 67:205, 1993
12. Vaux DL: Towards an understanding of the molecular mechanism of physiological cell death. Proc Natl Acad Sci USA 90:786, 1993
13. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
14. Sachs L, Lotem J: Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 82:15, 1993
15. Eastman A, Barry MA: The origins of DNA breaks: A consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest 10:229, 1992
16. Wijsman JH, Jonker RR, Keijzer R, Van De Velde CJH, Cornellise CJ, Dierendonck JHV: A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41:7, 1993
17. Giavrieli Y, Sherman Y, Ben-Sasson SA: Identification of Programmed Cell Death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
18. Rosi F: A simple and rapid method for detection of apoptosis in human cells. Nucleic Acid Res 20:5243, 1992
19. Gold R, Schmied M, Rothe G, Zischler H, Breitschope H, Wekerle H, Lassmann H: Detection of DNA fragmentation in apoptosis: Application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem 41:1023, 1993
20. Raza A, Bokahari J, Yousuf N, Mehdi A, Mazewski C, Khan S, Baker V, Lampkin B: Cell cycle kinetic studies in human cancers: Development of three DNA-specific labels in three decades. Arch Pathol and Lab Med 115:873, 1991
21. Mundle S, Iftikhar A, Shetty V, Alvi S, Dameron S, Gregory S, Marcus B, Khan S, Raza A: In Situ End Labeling of DNA to detect apoptotic cell death in a variety of human tumors. Cell Death and Differentiation 1:117, 1994
22. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shetty V, Dameron S, Wright V, Adler S, Loew J, Shott S, Ali N, Preisler H: Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 48:143, 1995
23. 3HTdr. Leuk Res 11:1079, 1987
24. Raza A, Yousuf N, Bokhari SAJ, Sheikh Y, Akhtar S, Chughtai S, Umerani A, Mehdi SA, Miller MA, Masterson M, Lampkin B: In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies. Anti Cancer Res 12:403, 1993
25. Bennett JM, Catovsky D, Flandrin DMT, Gallon DAG, Gralnick HR, Sultan C: Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
26. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal oxynucleotidyl transferase and nick translation assays. Cancer Res 53:1945, 1993
27. Fehsel K, Kolb-Bachofen V, Kolb H: Analysis of TNF-α induced DNA strand breaks at the single cell level. Am J Pathol 139:251, 1991
28. Jonker RJ, Bavmann JG, Visser JW: Detection of apoptosis with in situ nick translation. Cytometry 85:44, 1991
29. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, and Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal deoxynucleotidly transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:639, 1992
30. Clark DM, Lampert IA. Apoptosis is a common histopathological finding in myelodysplasia: The correlate of ineffective hematopoiesis. Leuk Lymphoma 2:415, 1990
31. Hibner U, Coutinho A: Signal antonymy: A mechanism for apoptosis induction. Cell Death Differentiation 1:33, 1994
32. Ohyashiki K, Ohyashiki JH, Fujimura T, Toyama K: An assoation between telomere shortening and disease evolution patterns in MDS. Leuk Res 18:9, 1994 (suppl)
33. Shetty V, Sanoy A, Alvi S, Payne G, Mundle S, Iftilchar A, Marcus B, Loew J, Adler S, Gregory S, Raza A: High levels of transforming growth factor beta (JGF-β) and large number of macrophages in the hematopoietic microenvironment (HME) of patients with myelodysplastic syndromes (MDS) associated with extensive apoptosis of both stromal and parenchymal cells. Proc Am Soc of Clin Oncol 13:129, 1994 (abstr)
34. Shetty V, Sanoy A, Payne G, Mundle S, Marcus B, Loew J, Wright V, Adler S, Gregory S, Raza A: High degree of TNF-α may be responsible for extensive apoptosis of bone marrow cells in MDS. Cell Prolif 27:411, 1994 (abstr)
35. Dezube BJ, Pardee AB, Chapman B, Beckett LA, Korvick JA, Novick WJ, Chiurco J, Kasdan P, Ahlers CM, Ecto LT, Crumpacker CS, and the NIAID AIDS Clinical Trials Group. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J Acquir Immune Defic Syndromes 6:787, 1993